Vast has opened a call for scientific research aboard its Haven-1 private space station, which is set to launch next year.
The California-based startup is soliciting proposals for ground-based and space-based experiments to fly aboard Haven-1 as well as for potential private crewed missions to the International Space Station (ISS), although the latter are contingent on awards by NASA.
The company, which has moved fast since its founding in 2021, says Haven-1 is well kitted out to host experiments in a diverse range of areas, including on-orbit pharmaceutical development, stem cell research, plant growth and human research and tech demos.
“The opportunity to expand access to microgravity research upon the world’s first commercial space station is historic,” Vast Principal Scientist Meghan Everett said in a statement. “We need to build on the heritage of the ISS National Lab and help scientists and industry continue world-changing research breakthroughs that are only possible in the novel environment of microgravity.”
Vast adds that it is keen on research that could assist human exploration of the moon and Mars and breakthroughs that can benefit humans on Earth, such as studies of bone, muscle and cardiac health, medical tech and stem cell research and regenerative medicine. Vast has already secured partners for Haven-1 including Redwire, Yuri, Japan Manned Space Systems Corporation (JAMSS), Interstellar Lab and Exobiosphere.
In early November, Vast’s Haven Demo launched on a Falcon 9 aiming to test critical systems for Haven-1 in orbit. Haven-1 itself is planned to be a stepping stone to a larger and more permanent presence in space, according to Vast, with the company aiming to secure support for the planned Haven-2 habitat through NASA’s Commercial LEO Destinations program.
